Insight 2811 Inc’s Merck MRK Stock Holding History

Insight 2811 Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5	Closed	-$3K	–	154
2014 Q3	$3K	Buy	+5	New	+$281	﹤0.01%	157

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Insight 2811 Inc's MRK Position: Q1 2026 in Review

Insight 2811 Inc reduced its Merck (MRK) stake by 10% in Q1 2026, selling an estimated $77.7K and leaving 5,737 shares worth $690K. The position accounts for 0.29% of the portfolio, ranked #43.

Insight 2811 Inc first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.05M in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Insight 2811 Inc held 5,737 shares of Merck worth $690K as of Q1 2026.
Insight 2811 Inc sold 673 Merck shares in Q1 2026, an estimated $77.7K.
Merck made up 0.29% of Insight 2811 Inc's portfolio in Q1 2026, its #43 holding.
Insight 2811 Inc first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
Insight 2811 Inc's Merck position peaked at $1.05M in Q2 2023.
3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Insight 2811 Inc's 13F filing for Q1 2026, filed 7 May 2026.